Anticorps Polyclonal de lapin anti-p21

p21 Polyclonal Antibody for WB, IF/ICC, IP, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat, souris

Applications

WB, IF/ICC, IP, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 28248-1-PBS

Synonymes

Cdkn1a, Cdkn1, P21 protein, p21Cip1, p21WAF



Informations sur le produit

28248-1-PBS cible p21 dans les applications de WB, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons rat, souris

Réactivité rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène p21 Protéine recombinante Ag28394
Nom complet cyclin-dependent kinase inhibitor 1A (P21)
Masse moléculaire calculée 18 kDa
Poids moléculaire observé 18 kDa
Numéro d’acquisition GenBankNM_001111099
Symbole du gène p21
Identification du gène (NCBI) 12575
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation.

{{ptg:RelatedPrimaryAntibodies}}